[1]
“PO44 | Emicizumab in acquired haemophilia A: M. Leotta, A. Strangio, A. Ierardi, S. Prejanò, R C. Santoro | Hemostasis and Thrombosis Unit, Department Hemato-Oncology, Azienda Ospedaliero-Universitaria Renato; Dulbecco, Catanzaro, Italy”, Bleeding Thromb Vascul Biol, vol. 4, no. s1, Aug. 2025, doi: 10.4081/btvb.2025.307.